FIELD: pharmacology.
SUBSTANCE: invention relates to pharmacology and relates to a composition for the preparation of an antitumor medication in the form of a solution for injection. Said composition contains alloferon in a concentration of 0.05 to 0.1 % by weight, cis-dichlorodiamine platinum in a concentration of 0.01 to 0.05 % by weight and water.
EFFECT: composition of the invention is characterized by antitumor activity and reduced toxicity.
1 cl, 1 dwg, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-TUMOR AND ANTIVIRAL PEPTIDES | 2004 |
|
RU2267496C2 |
| AGENT FOR EXTERNAL USE WITH ANTIVIRAL ACTION | 2021 |
|
RU2819719C2 |
| METHOD OF PRODUCING A DRUG BASED ON OLIGOPEPTIDE ALLOFERON-1, HAVING AN ANTIVIRAL AND IMMUNOMODULATING EFFECT, AND PROLONGED STORAGE MEDICINAL PRODUCT OBTAINED WITH ITS HELP | 2017 |
|
RU2737852C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING BIOLOGICALLY ACTIVE ALLOFERON AND ZINC COMPLEXES AND METHOD OF PRODUCTION THEREOF | 2019 |
|
RU2742565C1 |
| ALLOPHERONES AS IMMUNOMODULATING PEPTIDES | 1999 |
|
RU2172322C1 |
| METHOD FOR SYNTHESIS OF PLATINUM (II) COMPLEX WITH DNA, SHOWING ANTITUMOR ACTIVITY | 0 |
|
SU1754722A1 |
| CIS-CHLORODIAMINE-1,3-DIMETHYLXANTHINE PLATINUM (II) CHLORIDE DIHYDRATE | 1990 |
|
SU1790190A1 |
| METHOD OF PREPARING OF COMPLEX PLATINUM (II) COMPOUND WITH NATIVE DNA SHOWING ANTITUMOR ACTIVITY | 0 |
|
SU1813089A3 |
| CIS-CHLORO-N′-((2′--TETRAHYDROFURYL)-5-FLUOROURACILATODIAMMIN- -PLATINUM (II) SHOWING ANTITUMOR ACTIVITY | 1992 |
|
RU2028301C1 |
| ANTICANCER AGENT | 2001 |
|
RU2178702C1 |
